JP2010523598A5 - - Google Patents

Download PDF

Info

Publication number
JP2010523598A5
JP2010523598A5 JP2010502350A JP2010502350A JP2010523598A5 JP 2010523598 A5 JP2010523598 A5 JP 2010523598A5 JP 2010502350 A JP2010502350 A JP 2010502350A JP 2010502350 A JP2010502350 A JP 2010502350A JP 2010523598 A5 JP2010523598 A5 JP 2010523598A5
Authority
JP
Japan
Prior art keywords
peptide
terminus
modified
peptide chain
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010502350A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010523598A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/059591 external-priority patent/WO2008124698A2/en
Publication of JP2010523598A publication Critical patent/JP2010523598A/ja
Publication of JP2010523598A5 publication Critical patent/JP2010523598A5/ja
Pending legal-status Critical Current

Links

JP2010502350A 2007-04-06 2008-04-07 痛みの軽減のためのガンマ阻害剤化合物の使用方法 Pending JP2010523598A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91058807P 2007-04-06 2007-04-06
PCT/US2008/059591 WO2008124698A2 (en) 2007-04-06 2008-04-07 Methods of use of gamma inhibitor compounds for the attenuation of pain

Publications (2)

Publication Number Publication Date
JP2010523598A JP2010523598A (ja) 2010-07-15
JP2010523598A5 true JP2010523598A5 (enExample) 2012-07-12

Family

ID=39831558

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010502350A Pending JP2010523598A (ja) 2007-04-06 2008-04-07 痛みの軽減のためのガンマ阻害剤化合物の使用方法

Country Status (8)

Country Link
US (1) US20090062178A1 (enExample)
EP (1) EP2144615A4 (enExample)
JP (1) JP2010523598A (enExample)
CN (1) CN101969960A (enExample)
AU (1) AU2008237138B2 (enExample)
CA (1) CA2693256A1 (enExample)
MX (1) MX2009010757A (enExample)
WO (1) WO2008124698A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2124987A4 (en) * 2007-01-19 2012-05-02 Kai Pharmaceuticals Inc METHOD OF USE OF EPSILON HEMMER COMPOUNDS FOR PAIN LIFTING
AU2009288088B2 (en) * 2008-09-03 2014-12-04 Nono Inc. Agents and methods for treatment of pain
US11208446B2 (en) 2016-11-01 2021-12-28 Memorial Sloan Kettering Cancer Cenier Agents and methods for treating CBP-dependent cancers
IT201800009384A1 (it) * 2018-10-11 2020-04-11 Cosmo Srl Peptide for cosmetic application

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
US6376467B1 (en) * 1998-10-09 2002-04-23 The Regents Of The University Of California Use of inhibitors of protein kinase C epsilon to treat pain
MXPA02007674A (es) * 2000-02-08 2002-12-13 Amgen Inc Moleculas similares a interlucina-17 y uso de las mismas.
US7507711B2 (en) * 2002-04-22 2009-03-24 The Board Of Trustees Of The Leland Stanford Junior University Peptide inhibitors of protein kinase C
US6933275B2 (en) * 2002-05-01 2005-08-23 The Board Of Trustees Of The Leland Stanford Junior University Protein kinase C peptides for use in withdrawal
US7265092B2 (en) * 2004-09-30 2007-09-04 Kai Pharmaceuticals, Inc. Pharmaceutical formulation
EP2124987A4 (en) * 2007-01-19 2012-05-02 Kai Pharmaceuticals Inc METHOD OF USE OF EPSILON HEMMER COMPOUNDS FOR PAIN LIFTING

Similar Documents

Publication Publication Date Title
JP2014224126A5 (enExample)
JP2010534684A5 (enExample)
RU2016146198A (ru) Терапевтические dll4-связывающие белки
JP2010065037A5 (enExample)
NZ704192A (en) Cell-penetrating peptides and uses therof
MX2009000656A (es) Acidos nucleicos que se fijan a sdf-i.
IN2014CN02050A (enExample)
NZ591612A (en) Prevention, treatment and diagnosis of p.gingivalis infection with peptides
JP2013520426A5 (enExample)
NZ609216A (en) Anticancer fusion protein
WO2008133164A1 (ja) アミノ末端1箇所で配向制御固定化された固定化タンパク質
ATE482978T1 (de) Mimetische cd4-peptide und ihre verwendungen
MX2010003109A (es) Acidos nucleicos de enlace c5a.
JP2010523598A5 (enExample)
MX337801B (es) Acidos nucleicos que se enlazan on mcp-1.
WO2009047992A1 (ja) Udp-グルクロン酸転移酵素およびそれをコードするポリヌクレオチド
EA200901441A1 (ru) Новые молекулы антител и нуклеиновых кислот, связывающиеся с грибным белком теплового шока hsp90
JP2010265269A5 (enExample)
WO2008113536A8 (en) Neurotrophic peptides
WO2008066816A3 (en) Derivatization or ligaton of peptides
ATE453664T1 (de) Hausstaubmilbenallergen
JP2010512326A5 (enExample)
JP2015119721A5 (enExample)
WO2010057242A3 (de) Vakzin
JP2006503088A5 (enExample)